Posted by admin | Oct 12th, 2009

Ranbaxy gets USFDA nod for migraine drug

ndtv asked: Ranbaxy has bagged USFDA approval for Imitrex. DRL already sells Imitrex in US markets since November 24, 2008. Analysts expect Ranbaxy to do sales worth $15-20 million in Q4-FY ‘09. Imitrex has annual sales of $1-1.2 billion globally. … migraine drug USFDA Ranbaxy NDTV Profit...

Posted by admin | Oct 10th, 2009

Better Migraine Treatment

dailyhealthupdates asked: The latest research has found that adding antiinflammatory naproxen to imitrex gives patients more relief than using imitrex alone. Get more information at www.HealthyUpdates.com Get a FREE REMEDY Subscription www.healthisnow.com … naproxen imitrex combination pill migraine medication treatment relief headache...